Concorde Asset Management’s DexCom DXCM Stock Holding History

Concorde Asset Management’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-7,120	Closed	-$956K	–	166
2021 Q4	$956K	Buy	7,120 +36	+0.5%	+$5.17K	0.57%	66
2021 Q3	$968K	Buy	+7,084	New	+$893K	0.56%	58
2021 Q2	–	Sell	-3,672	Closed	-$330K	–	202
2021 Q1	$330K	Buy	3,672 +1,420	+63%	+$133K	0.19%	134
2020 Q4	$208K	Sell	2,252 -5,388	-71%	-$481K	0.12%	138
2020 Q3	$787K	Buy	+7,640	New	+$798K	0.45%	69

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Concorde Asset Management's DXCM Position: Q1 2022 in Review

Concorde Asset Management sold out of DexCom (DXCM) in Q1 2022, closing a stake of 7,120 shares — an estimated $956K sold.

Concorde Asset Management first reported a position in DXCM in Q3 2020 and held it in 5 quarters. The position peaked at $968K in Q3 2021. 861 funds tracked by Wall St. Rank hold DXCM as of Q1 2022.

Concorde Asset Management reported no remaining DexCom position as of Q1 2022 after selling out during the quarter.
Concorde Asset Management sold 7,120 DexCom shares in Q1 2022, an estimated $956K.
Concorde Asset Management first reported a position in DexCom in Q3 2020 and held it in 5 quarters.
Concorde Asset Management's DexCom position peaked at $968K in Q3 2021.
861 funds tracked by Wall St. Rank held DexCom as of Q1 2022.

Based on Concorde Asset Management's 13F filing for Q1 2022, filed 22 Apr 2022.